longevity
Beyond Market Intelligence keeps longevity in one place: 2 stories so far. The section currently leads with “Ultrahuman and Abu Dhabi partner to validate biological-age model over two years” and “A billion-dollar bet on longevity backed by customer value, not equity.”. Two years of clinical validation sounds like the right kind of patience for a model that claims to measure biological age. General Catalyst's Customer Value Fund is taking a different route to back IM8, David Beckham's longevity vitamin drink startup, with a $1 billion commitment that skips equity entirely. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work… The list below is every longevity story on Beyond Market Intelligence, newest first.

Ultrahuman and Abu Dhabi partner to validate biological-age model over two years
Two years of clinical validation sounds like the right kind of patience for a model that claims to measure biological age. Ultrahuman and Abu Dhabi are committing to real research, not just a flashy launch. That matters. If you are curious about how AI is quietly reshaping other unexpected areas, our piece on AI-powered weather balloons winning a military contract offers a fascinating parallel.

A billion-dollar bet on longevity backed by customer value, not equity.
General Catalyst's Customer Value Fund is taking a different route to back IM8, David Beckham's longevity vitamin drink startup, with a $1 billion commitment that skips equity entirely. It's a bold structure, and it signals real confidence in the brand's momentum. If you're watching how capital flows to consumer health, this is a deal worth exploring. For more on how big bets are reshaping infrastructure, check out our piece on Nscale's $3.36B raise. The pattern is clear: money is moving where the value is.